Case 2: Faricimab in treatment naïve neovascular nAMD patient
Drs Khanani and Khoramnia review the case of a newly diagnosed nAMD patient who showed a rapid response in disease control after starting faricimab therapy.
Sponsored by Roche
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
